NCT04096287View on ClinicalTrials.gov

Safety and Tolerability of PNT001 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Healthy
Interventions
BIOLOGICAL

PNT001

PNT001 diluted in 5% dextrose

DRUG

Placebo

5% dextrose

Trial Locations (4)

72758

Woodland Research Northwest, Rogers

78217

Worldwide Clinical Trials, San Antonio

92103

Pacific Research Network, Inc., San Diego

08053

Hassman Research Institute, Marlton

Sponsors
All Listed Sponsors
lead

Pinteon Therapeutics, Inc

INDUSTRY